Načítá se...
Real World Outcomes of Left Atrial Appendage Occlusion
Percutaneous left atrial appendage occlusion (LAAO) is a device-based therapy for the prevention of stroke in patients with non-valvular atrial fibrillation (AF). Recently, the Watchman device (Boston Scientific, St Paul, MN, US) was approved in the US by the Food and Drug Administration (FDA) based...
Uloženo v:
| Vydáno v: | Interv Cardiol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Radcliffe Cardiology
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5808629/ https://ncbi.nlm.nih.gov/pubmed/29588685 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15420/icr.2015.10.2.109 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|